Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1GLQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,980
Award facts
- Contract value 100% obligated
- $33,979.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $33,979.74 delivery order to AmerSourceBergen Drug Corp for GARDASIL 9 syringes (0.5mL) on January 28, 2026, with completion scheduled for January 29, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The order represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9 million through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerSourceBergen Drug Corp functions as a major pharmaceutical distributor within the federal supply chain, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The delivery of GARDASIL 9 vaccine syringes under this order supports immunization programs across the Department of Defense healthcare enterprise. The parent company's substantial IDC with DLA reflects its established capability to fulfill competitive federal procurement requirements for a comprehensive range of brand-name and generic pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F1GLQ?
SPE2DR26F1GLQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F1GLQ worth?
The government has obligated $33,980 on SPE2DR26F1GLQ.
Is contract SPE2DR26F1GLQ an order under another contract?
Yes. SPE2DR26F1GLQ is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GLQ competed?
The extent of competition for SPE2DR26F1GLQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award